According to Rich et al., osteonectin (SPARC) and semaphorin3B are equally important genes involved in the regulation of cell migration, when combined with DCX, these genes may act as predictive genetic markers for the survival of GBM patients. This evidence concerns the gene SPARC and glioblastoma.